Maintenance Services for the NovaSeq X Plus Sequencer

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition to Illumina, Inc. for maintenance services of the NovaSeq X Plus Sequencer. The Genomic Technology Section within NIAMS has utilized Illumina, Inc. for maintenance services since 2024 due to the complexity of the system, which requires manufacturer-trained technicians with access to original equipment parts. Key points to consider: • The contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1. • The acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). • Interested parties may identify their interest and capability to respond to this notice, and responses must be received by May 28, 2026, at 9:00 AM Eastern time.